Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Schering-Plough to Buy Akzo’s Pharma Unit
11:52 AM MDT | July 26, 2007 | Alex Scott and Kerri Walsh
Akzo Nobel says it has agreed to sell its pharmaceuticals business Organon BioSciences (OBS) to Schering-Plough for €11 billion ($14.5 billion). The companies expect the deal to be completed in the second half, following regulatory approval. The divestiture would provide Akzo with extra cash, which has rekindled some expectations that Akzo plans to bid for ICI, media reports say. The deal will fill a gap in Schering-Plough’s late-stage drug development pipeline by adding five compounds in Phase III development and several “promising projects in...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee